IL18 and hyperuricemia: Hyperuricemia amplifies these processes: xanthine oxidase-derived reactive oxygen species, reduced nitric-oxide bioavailability, and, to a larger extent, NLRP3 inflammasome activation (IL-1β/IL-18) allow for near-constant “inflammatory priming” [20].